RxDoctor Payments DataLook up a doctor →

Stacy Smith, MD

Neuro-ophthalmology · Bellaire, TXNPI 1306138235

Payments from drug & device makers

$224,723in general payments, 2019–2025

Across 902 payments — averaging $249.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$70K
  • Lilly USA, LLC$65K
  • Pfizer$41K
  • AbbVie$24K
  • Biohaven Pharmaceutical Holding Company Ltd.$18K
  • AstraZeneca$937
  • plus $6K from 46 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few neuro-ophthalmology providers in Texasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$157,803
Medicare patients
209
Services billed
14,869

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neuro-ophthalmology in Bellaire

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →